Steve Asmussen, North America's leading trainer in 2004 and 2005, is facing a six month suspension for a medication infraction involving the Class 2 drug mepivicaine, a local anesthetic.
According to the Louisiana Racing Commission, Asmussen's appeal on a May 18 ruling was rejected when stewards reviewed the issue June 23. The trainer was fined $2,500 and must postpone training July
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.
